Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contacto
Contáctenos
Ensayos Clínicos | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Apraglutide in Adult Subjects With Short Bowel Syndrome and Intestinal Failure (SBS-IF)
INTERVENTIONAL
Inicio: 26 de ene de 2021
ID: NCT04627025
Completado
Fase 3
ClinicalTrials.gov
A Double Blind Placebo Controlled Randomized Trial of PF-804 in Patients With Incurable Stage IIIB/IV Non-Small Cell Lung Cancer After Failure of Standard Therapy for Advanced or Metastatic Disease
INTERVENTIONAL
Inicio: 23 de dic de 2009
ID: NCT01000025
Completado
ClinicalTrials.gov
Efficacy of Eccentric Exercises in Individuals With Frozen Shoulder: A Randomized Controlled Clinical Trial
INTERVENTIONAL
Inicio: 3 de ago de 2022
ID: NCT04715035
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Open-label, Long-term Extension Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Pediatric Subjects With Epilepsy With Partial-Onset Seizures
INTERVENTIONAL
Inicio: 13 de ago de 2014
ID: NCT01964560
Terminado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Investigate the Efficacy and Safety of BGE-175 in Hospitalized Adults With COVID-19
INTERVENTIONAL
Inicio: 18 de mar de 2021
ID: NCT04705597
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Subjects With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma
INTERVENTIONAL
Inicio: 3 de sept de 2013
ID: NCT01855750
Desconocido
ClinicalTrials.gov
Non-selection Trial Comparing Metabolomics to PGT-A Embryo Selection Using Vitrolife G-TL Media
OBSERVATIONAL
Inicio: 12 de jul de 2021
ID: NCT04976920
Desconocido
Fase 4
ClinicalTrials.gov
Efficacy and Safety Study to Evaluate the Use of Nebulized Heparin in Patients With Severe Acute Respiratory Syndrome Covid-19 (SARS-CoV-2)
INTERVENTIONAL
Inicio: 1 de jun de 2020
ID: NCT04530578
Desconocido
ClinicalTrials.gov
Efficacy and Effectiveness of a Self-applied Online Program to Promote Resilience and Coping Skills in University Students in Three Spanish-speaking Countries: Study Protocol for a Randomized Controlled Trial
INTERVENTIONAL
Inicio: 1 de nov de 2018
ID: NCT03903978
Completado
ClinicalTrials.gov
Living Well, Dying Well. a Research Programme to Support Living Until the End (iLIVE)
OBSERVATIONAL
Inicio: 1 de sept de 2020
ID: NCT04271085
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Event-driven Phase 3 Study to Investigate the Safety and Efficacy of Finerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease
INTERVENTIONAL
Inicio: 17 de sept de 2015
ID: NCT02540993
Completado
ClinicalTrials.gov
Drug Interactions and Hip Fracture Risk in Older Adults
OBSERVATIONAL
Inicio: 16 de ago de 2018
ID: NCT04731597
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination With Metformin Therapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
INTERVENTIONAL
Inicio: 1 de jun de 2003
ID: NCT00162240
Completado
Fase 3
ClinicalTrials.gov
An Open-label, Randomized, Phase IIIb Trial Evaluating the Efficacy and Safety of Standard of Care +/- Continuous Bevacizumab Treatment Beyond Progression of Disease (PD) in Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) After First Line Treatment With Bevacizumab Plus a Platinum Doublet-containing Chemotherapy
INTERVENTIONAL
Inicio: 25 de jun de 2011
ID: NCT01351415
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma
INTERVENTIONAL
Inicio: 10 de mar de 2011
ID: NCT01327885
Completado
Fase 2
ClinicalTrials.gov
A Phase 2 Randomized, Double-blind, Placebo-controlled, Dose-ranging, Efficacy and Safety Study of SAR441566 Plus Methotrexate in Adults With ModeratetoSevere Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 7 de nov de 2023
ID: NCT06073093
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk
INTERVENTIONAL
Inicio: 27 de abr de 2018
ID: NCT03496298
Terminado
Fase 1
ClinicalTrials.gov
A Cross-sectional Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease
INTERVENTIONAL
Inicio: 1 de may de 2013
ID: NCT01839526
Completado
Fase 3
ClinicalTrials.gov
A Multi-center, Uncontrolled Extension Study Evaluating Efficacy and Safety of SAR153191 in Patients With Active Rheumatoid Arthritis (RA)
INTERVENTIONAL
Inicio: 21 de jun de 2010
ID: NCT01146652
Completado
Fase 3
ClinicalTrials.gov
A Comparative Study of the Antiviral Efficacy and Safety of Entecavir (ETV) Versus Placebo in Pediatric Subjects With Chronic Hepatitis B Virus (HBV) Infection Who Are HBeAg-Positive
INTERVENTIONAL
Inicio: 30 de jun de 2010
ID: NCT01079806
Anterior
1
...
413
414
415
...
434
Siguiente
Filtros